Table 1. Open in new tab Baseline... | Oxford Academic

Table 1.

Open in new tab

Baseline Characteristics

Characteristic	DTG + 3TC (n = 16)	BIC/FTC/TAF (n = 8)
Age, y	32 [26.75–38]	31 [24.5–39]
CD4 count, cells/μL	436.5 [270.5–597.25]	392 [345–442.25]
HIV-1 RNA
Blood plasma^a	4.56 [4.22–4.86]	4.48 [4.15–5.04]
Seminal plasma^a	2.38 [1.30–2.95]	2.71 [1.30–3.90]
Rectal fluid^b	2.92 [2.36–3.73]	3.55 [3.05–4.13]

Characteristic	DTG + 3TC (n = 16)	BIC/FTC/TAF (n = 8)
Age, y	32 [26.75–38]	31 [24.5–39]
CD4 count, cells/μL	436.5 [270.5–597.25]	392 [345–442.25]
HIV-1 RNA
Blood plasma^a	4.56 [4.22–4.86]	4.48 [4.15–5.04]
Seminal plasma^a	2.38 [1.30–2.95]	2.71 [1.30–3.90]
Rectal fluid^b	2.92 [2.36–3.73]	3.55 [3.05–4.13]

Data are presented as median [IQR].

Abbreviations: 3TC, lamivudine; BIC, bictegravir; DTG, dolutegravir; FTC, emtricitabine; TAF, tenofovir alafenamide.

Log₁₀ copies/mL.

Log₁₀ copies/swab.

Table 1.

Open in new tab

Baseline Characteristics

Characteristic	DTG + 3TC (n = 16)	BIC/FTC/TAF (n = 8)
Age, y	32 [26.75–38]	31 [24.5–39]
CD4 count, cells/μL	436.5 [270.5–597.25]	392 [345–442.25]
HIV-1 RNA
Blood plasma^a	4.56 [4.22–4.86]	4.48 [4.15–5.04]
Seminal plasma^a	2.38 [1.30–2.95]	2.71 [1.30–3.90]
Rectal fluid^b	2.92 [2.36–3.73]	3.55 [3.05–4.13]

Characteristic	DTG + 3TC (n = 16)	BIC/FTC/TAF (n = 8)
Age, y	32 [26.75–38]	31 [24.5–39]
CD4 count, cells/μL	436.5 [270.5–597.25]	392 [345–442.25]
HIV-1 RNA
Blood plasma^a	4.56 [4.22–4.86]	4.48 [4.15–5.04]
Seminal plasma^a	2.38 [1.30–2.95]	2.71 [1.30–3.90]
Rectal fluid^b	2.92 [2.36–3.73]	3.55 [3.05–4.13]

Data are presented as median [IQR].

Abbreviations: 3TC, lamivudine; BIC, bictegravir; DTG, dolutegravir; FTC, emtricitabine; TAF, tenofovir alafenamide.

Log₁₀ copies/mL.

Log₁₀ copies/swab.